Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and Therapy
Published: | Updated:
Khaled W. Kabbara, MD, and colleagues, research treatment options for cholangiocarcinoma.
Timothy Cannon, MD
Advertisement
Articles by Timothy Cannon, MD
Advertisement
Latest Updated Articles
Molecular Pathogenesis of Cholangiocarcinoma: Implications for Disease Classification and TherapyPublished: August 19th 2022 | Updated: June 21st 2023
Advertisement
Advertisement
Trending on CancerNetwork
1
Will The FDA Approve Iberdomide in Relapsed/Refractory Multiple Myeloma?
2
FDA Grants Tentative Approval to PNT2003 for GEP-NETs
3
DURGA-1 Trial Shows Encouraging Results With Novel Multiple Myeloma Agent
4
What Were The Key Prostate Cancer Abstracts at ASCO GU 2026?
5